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June Supplement 201164S Abstractsregimes after PTA, stenting, and SAP were ASA-only
(47%), ASA-clopidogrel (38%), and ASA-clopidogrel
(41%), respectively. Type of post-procedure antithrom-
botic therapy did not influence major amputation or death
in claudicants or patients with critical limb ischemia (CLI)
undergoing PTA or SAP. Kaplan-Meier analysis showed
better amputation-free survival and total survival with ASA-
clopidogrel treatment compared to ASA-only in patients
with CLI undergoing stenting (log rank P0.008 and
P0.047, respectively).
Conclusions: Patients with CLI undergoing stenting
in the femoropopliteal segment have insufficient adjuvant
antiplatelet treatment and dual antiplatelet therapy with
ASA and clopidogrel seem to improve amputation-free
survival. Type of post-procedure antiplatelet therapy did
not influence amputation or death in patients with CLI
undergoing PTA or SAP.
Author Disclosures: F. Granath: Nothing to disclose; J.
Malmstedt: Nothing to disclose; O. Thott: Nothing to
disclose; C. Wahlgren: Nothing to disclose.
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An Economic Analysis Regarding the Use of Axial
Imaging Studies for the Anatomic Workup of Periph-
eral Arterial Occlusive Disease
Bryan A. Ehlert, John T. Nelson, Christopher A. Durham,
Alex J. Ferikes, Charles S. Powell, WilliamM. Bogey, Frank
M. Parker, Michael C. Stoner. East Carolina University,
Greenville, NC
Objectives: Within the context of healthcare resource
utilization, the optimal use of computed tomographic ar-
teriography (CTA) for peripheral arterial occlusive disease
is ill-defined. The purpose of this study is to use data from
a contemporary practice to examine the hypothetical im-
pact of non-selective CTA as a part of the workup algorithm
for peripheral arterial occlusive disease.
Methods: Outpatient lower extremity endovascular
cases were analyzed over a consecutive 12-month period.
Indication (claudication or critical limb ischemia), case type
(diagnostic or interventional) and charges were recorded.
Medicare charges for CTAwere used to generate hypothet-
ical charges assuming all patients underwent CTA, and that
diagnostic cases would not have undergone catheter-based
procedures. The ratio of diagnostic to interventional cases
was then examined to define the cost-effective point for
non-selective CTA use.
Results: A total of 211 cases were identified, 47% had an
indication of claudication, and 60% were male. In the claudi-
cation cohort, 32% were diagnostic and the mean current
charge (without the use of CTA) was $45,8733,002/pa-
tient. Non-selective CTA results in a mean charge
of $47,5573,545/patient (P0.72 vs. current). In the crit-
ical limb ischemia subset, 29% were diagnostic, and the mean
current charge was $52,5423,690/patient compared to a
hypothetical non-selective CTA charge of $55,7954,144/atient (P0.55 vs. current). The ratio of diagnostic-to-inter-
entional cases for non-selective CTA to be cost-effective is
.44.
Conclusions:The economic basis for non-selective use
f CTA in the anatomic workup of peripheral arterial
cclusive disease is dependent on the ratio of diagnostic to
nterventional cases. In the authors’ current practice, non-
elective CTA would not improve resource utilization,
owever other factors such as patient access, the invasive
ature of catheter-based procedures, ionizing radiation
osimetry, and iodinated contrast dose all impact this prac-
ice decision.
uthor Disclosures: W. M. Bogey: Nothing to disclose;
. A. Durham: Nothing to disclose; B. A. Ehlert: Nothing
o disclose; A. J. Ferikes: Nothing to disclose; J. T. Nelson:
othing to disclose;F. M. Parker: Nothing to disclose;C. S.
owell: Nothing to disclose; M. C. Stoner: Nothing to
isclose.
S134.
mplications of Improved Amputation Free Survival in
nreconstructable CLI in the Modern Era
ric Benoit1, Thomas F. O’Donnell1, Georgios Kitsios2,
ark D. Iafrati1. 1The Cardiovascular Center, Tufts Med-
cal Center, Boston, MA; 2Tufts Evidence - Based Practice
enter, Institute for Clinical Research and Health Policies
tudies, Boston, MA
Objectives: Patients with no option critical limb isch-
mia [NOCLI] have been ascribed a 50% one-year ampu-
ation free survival (AFS) [TASC II]. Over recent years
mprovements in the medical treatments available to NO-
LI patients may affect atherosclerotic peripheral and cor-
nary artery disease. In addition advances in wound care
herapies have improved ulcer healing. We sought to deter-
ine if amputation, mortality, and AFS rates of medically
anaged NOCLI patients have changed over the last two
ecades.
Methods: We reviewed 886 control patients from 11
OCLI randomized controlled trials (RCTs)enrolled from
988 to 2010. We estimated summary proportions of
vents at 1 year by conducting a random effects meta-
nalysis of proportions with the Freeman-Tukey arcsine
ransformation method. To examine whether there is a
ignificant change in the published proportions of these
vents over time, we performed a random effects meta-
egression analysis, where we regressed the proportion of
vents in each study against the indicator variable “final year
f recruitment” in each study. This was used as a proxy
ariable for the time period during which each study was
onducted. We examined the coefficient of this indicator
ariable for direction of effect (positive or negative, show-
ng increase or decrease in proportion of events over time,
espectively).Results: See Table.
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Volume 53, Number 17S Abstracts 65SConclusions: During the last two decades the natural
history of medically treated No Option CLI has improved.
Reduction in the AFS composite measure was predomi-
nantly influenced by mortality. A composite outcome
which includes survival may blur the limb specific benefits
of an intervention. The changing natural history data has
important implications for power calculations and endpoint
selection of future NOCLI trials.
Natural History of NOCLI
Outcome
(1 year)
Summary
Proportion
Coefficeint of\”final
Year Recruitment\”
p
Value
Amputation 0.35 (0.25, 0.46) 0.0252 (0.0621, 0.0117) 0.157
Death 0.18 (0.09, 0.31) 0.047 (0.9482, 0.0014) 0.056
AFS 0.55 (0.40, 0.69) 0.052 (0.001, 0.104) 0.047
Author Disclosures: E. Benoit: Nothing to disclose;
M. D. Iafrati: Nothing to disclose; G. Kitsios: Nothing to
disclose; T. F. O’Donnell: Nothing to disclose.
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Variation in the Use of Invasive Revascularization for
Severe Lower Extremity PAD in the Year Prior to
Amputation
Philip P. Goodney1, Nicholas H. Osborne3, Jack L.
Cronenwett1, Richard J. Powell1, F. Lee Lucas2, John D.
Birkmeyer3, Elliott S. Fisher1. 1Section of Vascular Sur-
gery, Dartmouth-Hitchcock Medical Center, Lebanon,
NH; 2Center for Outcomes Research and Evaluation, Port-
land, ME; 3University of Michigan, Ann Arbor, MI
Objectives: Many believe limited access to vascular
care represents a significant barrier in preventing lower
extremity amputation. Therefore, we sought to describe
the variation in vascular care obtained by patients with PAD
during the year prior to amputation.
Methods: Using Medicare claims (2003-2006), we
identified all patients with a diagnosis of PAD who under-
went major lower extremity amputation (n22,208) in
each of the 304 hospital referral regions (HRRs) described
in the Dartmouth Atlas of Healthcare. For each patient, we
studied the use of revascularization procedures (bypass
surgery or endovascular interventions) in the year prior to
amputation. Our main outcome measure was the intensity
of vascular care, defined as the proportion of patients in the
HRR who underwent any revascularization procedure in
the year prior to amputation.
Results: Overall, we studied 22,208 patients with
PAD who underwent 29,559 major lower extremity
amputations. In the year prior to amputation, vascular
intensity varied across regions. In the regions in the
lowest quintile of vascular intensity, lower extremity
revascularization was rarely attempted in the year prior
to amputation (1% of patients underwent bypass surgery,
1% endovascular interventions). Conversely, in the re-
gions in the highest quintile of vascular intensity, revas-
cularization was much more commonly performed in the uear prior to amputation (49% of patients underwent
ypass surgery, 48% endovascular interventions). Within
uintiles of vascular intensity, regions tended to use
ypass surgery and endovascular interventions similarly
Figure 1).
Conclusions: Dramatic disparities exist in the intensity
f vascular care provided to patients in the year prior to
mputation. In some regions, patients receive very intensive
are, while in other regions, far less vascular care is pro-
ided. Future work is needed to determine the association
etween intensity of vascular care and outcomes in the
reatment of patients with CLI.
uthor Disclosures: J. D. Birkmeyer: Nothing to dis-
lose; J. L. Cronenwett: Nothing to disclose; E. S. Fisher:
othing to disclose; P. P. Goodney: Nothing to disclose;
. Lucas: Nothing to disclose; N. H. Osborne: Nothing
o disclose; R. J. Powell: Nothing to disclose.
S138.
id-Term Results of a Novel Regenerative Xenograft
ascular Patch
lan Dardik1, György Acsády2, Lajos Mátyás3, Istvan
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ale University School of Medicine, New Haven, CT;
Semmelweis University Hospital, Budapest, Hungary;
Miskolc Hospital, Miskolc, Hungary; 4Szent Imre Hospi-
al, Budapest, Hungary; 5St. Elisabeth Hospitaal, Willem-
tad, Netherlands Antilles
Objectives: Prosthetic patches are commonly used to
lose arteriotomies such as performed after carotid or
emoral endarterectomy (FEA). Currently available syn-
hetic patches typically have poor compliance and are
rone to inflammatory infiltrates, contributing to long-
erm restenosis or pseudoaneurysm formation. We eval-
ariation in the Use of Invasive Lower Extremity Revasculariza-
ion, by Hospital Referral Region.ated the performance of a novel acellular, uncross-
